Vera Therapeutics, Inc.
VERA · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$80,293 | -$76,531 | -$51,694 | -$43,425 |
| Dep. & Amort. | $129 | $119 | $85 | $55 |
| Deferred Tax | $0 | $0 | $0 | $0 |
| Stock-Based Comp. | $9,745 | $9,472 | $7,744 | $6,217 |
| Change in WC | $8,686 | $13,382 | -$9,438 | -$728 |
| Other Non-Cash | -$173 | -$1,240 | -$1,103 | -$1,301 |
| Operating Cash Flow | -$61,906 | -$54,798 | -$54,406 | -$39,182 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$133 | -$208 | -$187 | -$645 |
| Net Acquisitions | $0 | $0 | $0 | $0 |
| Inv. Purchases | -$98,696 | -$94,728 | -$89,992 | -$294,015 |
| Inv. Sales/Matur. | $168,590 | $126,061 | $106,246 | $73,277 |
| Other Inv. Act. | $0 | -$2,581 | -$750 | $0 |
| Investing Cash Flow | $69,761 | $28,544 | $15,317 | -$221,383 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $0 | $19,821 | $0 | $0 |
| Stock Issued | $0 | $464 | $0 | $345,000 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $797 | $0 | $1,533 | -$19,045 |
| Financing Cash Flow | $797 | $20,285 | $1,533 | $325,955 |
| Forex Effect | $0 | $0 | $0 | $0 |
| Net Chg. in Cash | $8,652 | -$5,969 | -$37,556 | $65,390 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $49,121 | $55,090 | $92,646 | $27,256 |
| End Cash | $57,773 | $49,121 | $55,090 | $92,646 |
| Free Cash Flow | -$62,039 | -$55,006 | -$54,593 | -$39,827 |